Incannex Healthcare Inc
George Williams Mbogo is an accomplished research and regulatory scientist with extensive experience in clinical drug development and regulatory submissions. Currently at Incannex Healthcare Inc since August 2022, George supports R&D programs throughout clinical development toward regulatory filings. Previous roles include Senior Research & Development Associate at Incannex Healthcare Ltd and Regulatory Submissions Coordinator at Medpace, where George managed site activation and global regulatory compliance. With a strong foundation in scientific research, demonstrated through roles such as Technical Officer at Nucleus Network and Postdoctoral Research Officer at Burnet Institute, George's expertise spans areas including pre-clinical drug development and molecular epidemiology. Educational qualifications include a PhD in Biochemistry from La Trobe University, along with Master's and Bachelor's degrees in Molecular Biology and Biomedical Laboratory Technology, respectively.
This person is not in any teams
Incannex Healthcare Inc
Incannex is a clinical-stage pharmaceutical development company focused on discovering and developing life-changing medicines for patients struggling with serious, chronic diseases and limited treatment options. A leader in innovating proprietary cannabinoid pharmaceuticals and psychedelic-based therapies, we are developing medicines with the potential to alter the lives of patients suffering from obstructive sleep apnea (OSA), generalized anxiety disorder (GAD), and inflammatory disorders such as rheumatoid arthritis (RA). Working together in these relatively new fields with clinical, scientific, and drug development experts, we are efficiently innovating big solutions that are specifically designed and formulated to make a meaningful difference in patients’ lives. Founded in 2015 and headquartered in Melbourne, Australia, we are expanding in the U.S. and worldwide to help more patients and their families. Incannex trades on the Nasdaq Global Market under the symbol IXHL.